CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: N-(6-acetamidohexyl)acetamide
Accession: CHEBI:125472
browse the term
Definition: An acetamide that has formula C10H20N2O2.
Synonyms: exact_synonym: hexamethylene bisacetamide
related_synonym: Formula=C10H20N2O2; InChI=1S/C10H20N2O2/c1-9(13)11-7-5-3-4-6-8-12-10(2)14/h3-8H2,1-2H3,(H,11,13)(H,12,14); InChIKey=BNQSTAOJRULKNX-UHFFFAOYSA-N; SMILES=CC(=O)NCCCCCCNC(=O)C
alt_id: MESH:C014026
xref: HMDB:HMDB0041901; LINCS:LSM-36966
xref_mesh: MESH:C014026
G
Bax
BCL2 associated X, apoptosis regulator
affects expression
ISO
hexamethylene bisacetamide affects the expression of BAX
CTD
PMID:15543656
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:105,076,473...105,086,429
G
Bcl2
BCL2, apoptosis regulator
affects expression
ISO
hexamethylene bisacetamide affects the expression of BCL2
CTD
PMID:15543656
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:23,204,464...23,366,900
G
Bcl2a1
BCL2-related protein A1
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA; [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA
CTD
PMID:12130515
NCBI chr 8:98,596,806...98,604,890
Ensembl chr 8:98,596,650...98,604,890
G
Bcl2l1
Bcl2-like 1
affects expression
ISO
hexamethylene bisacetamide affects the expression of BCL2L1
CTD
PMID:15543656
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:161,745,540...161,764,907 Ensembl chr 1:161,745,540...161,764,907
G
Brd2
bromodomain containing 2
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [BRD2 protein binds to SRM promoter]
CTD
PMID:26941288
NCBI chr20:4,728,282...4,737,286
Ensembl chr20:4,728,951...4,737,290
G
Ccne1
cyclin E1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CCNE1 mRNA
CTD
PMID:17349212
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:99,918,674...99,927,822
G
Cd2
Cd2 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD2 mRNA
CTD
PMID:26941288
NCBI chr 2:191,399,510...191,412,659
Ensembl chr 2:191,399,510...191,413,665
G
Cd44
CD44 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD44 mRNA
CTD
PMID:17349212
NCBI chr 3:109,610,824...109,699,776
Ensembl chr 3:109,612,054...109,699,424
G
Cd52
CD52 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD52 mRNA
CTD
PMID:26941288
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:151,603,524...151,605,086
G
Cd69
Cd69 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD69 mRNA
CTD
PMID:26941288
NCBI chr 4:162,725,446...162,733,364
Ensembl chr 4:164,411,485...164,419,509
G
Cd74
CD74 molecule
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CD74 mRNA
CTD
PMID:26941288
NCBI chr18:56,527,071...56,536,406
Ensembl chr18:56,527,132...56,536,410
G
Cdc6
cell division cycle 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDC6 mRNA
CTD
PMID:26941288
NCBI chr10:84,360,361...84,374,239
Ensembl chr10:84,360,381...84,374,241
G
Cdc7
cell division cycle 7
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDC7 mRNA
CTD
PMID:26941288
NCBI chr14:2,804,660...2,824,796
Ensembl chr14:2,949,539...2,969,656
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDK2 mRNA
CTD
PMID:26941288
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,714,392...1,721,878
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
hexamethylene bisacetamide results in increased expression of CDKN1A mRNA; hexamethylene bisacetamide results in increased expression of CDKN1A protein [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CDKN1A mRNA
CTD
PMID:10597302 PMID:12130515 PMID:17349212
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,153,958...7,164,969
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
hexamethylene bisacetamide results in increased expression of CDKN1B mRNA
CTD
PMID:17349212
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:169,490,876...169,496,498
G
Cdt1
chromatin licensing and DNA replication factor 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of CDT1 mRNA
CTD
PMID:26941288
NCBI chr19:67,529,249...67,534,195
Ensembl chr19:67,529,201...67,534,194
G
Cebpe
CCAAT/enhancer binding protein epsilon
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of CEBPE mRNA; [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of CEBPE mRNA
CTD
PMID:12130515
NCBI chr15:32,139,716...32,141,476
Ensembl chr15:32,139,716...32,141,476
G
Chd4
chromodomain helicase DNA binding protein 4
multiple interactions
ISO
[Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [CHD4 protein binds to OGT protein]; [Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [thiamet G results in increased O-linked glycosylation of CHD4 protein]; [Hemin co-treated with hexamethylene bisacetamide] results in decreased O-linked glycosylation of CHD4 protein
CTD
PMID:27231347
NCBI chr 4:157,898,503...157,931,632
Ensembl chr 4:159,584,654...159,617,866
G
Csf1r
colony stimulating factor 1 receptor
increases expression
ISO
hexamethylene bisacetamide results in increased expression of CSF1R mRNA
CTD
PMID:8445950
NCBI chr18:56,834,152...56,860,804
Ensembl chr18:56,817,049...56,860,806
G
Dbf4
DBF4-CDC7 kinase regulatory subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of DBF4 mRNA
CTD
PMID:26941288
NCBI chr 4:25,676,570...25,701,152
Ensembl chr 4:26,631,514...26,656,562
G
Dusp6
dual specificity phosphatase 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of DUSP6 protein mutant form
CTD
PMID:17569113
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:35,977,921...35,983,833
G
Eif6
eukaryotic translation initiation factor 6
increases expression
ISO
hexamethylene bisacetamide results in increased expression of EIF6 protein
CTD
PMID:17569113
NCBI chr 3:144,325,038...144,331,396
Ensembl chr 3:164,785,163...164,791,525
G
Hba-a1
hemoglobin alpha, adult chain 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HBA-A1 mRNA
CTD
PMID:26941288
NCBI chr10:15,841,724...15,842,580
Ensembl chr10:15,841,763...15,842,603
G
Hexim1
HEXIM P-TEFb complex subunit 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HEXIM1 mRNA; hexamethylene bisacetamide results in increased expression of HEXIM1 protein
CTD
PMID:16222702
NCBI chr10:88,062,808...88,064,920
Ensembl chr10:88,560,519...88,580,000
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of HMOX1 mRNA]
CTD
PMID:12042074
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
G
Hoxa9
homeobox A9
increases expression
ISO
hexamethylene bisacetamide results in increased expression of HOXA9 protein
CTD
PMID:16973558
NCBI chr 4:81,323,235...81,329,344
Ensembl chr 4:82,653,825...82,662,093
G
Hpx
hemopexin
multiple interactions
ISO
hexamethylene bisacetamide inhibits the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of HMOX1 mRNA]; hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT2 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA]
CTD
PMID:12042074
NCBI chr 1:169,344,647...169,352,155
Ensembl chr 1:169,344,583...169,352,156
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of IFIT3 mRNA
CTD
PMID:12130515
NCBI chr 1:232,114,166...232,119,311
Ensembl chr 1:241,526,880...241,532,521
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of IGFBP2 mRNA
CTD
PMID:26941288
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:81,864,783...81,892,171
G
Itgam
integrin subunit alpha M
increases expression
ISO
hexamethylene bisacetamide results in increased expression of ITGAM protein
CTD
PMID:10597302
NCBI chr 1:192,089,496...192,139,947
Ensembl chr 1:192,089,542...192,139,943
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation increases expression
ISO
hexamethylene bisacetamide results in increased phosphorylation of JUN protein hexamethylene bisacetamide results in increased expression of JUN protein
CTD
PMID:10597302
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:114,973,151...115,013,285
G
Mcm10
minichromosome maintenance 10 replication initiation factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM10 mRNA
CTD
PMID:26941288
NCBI chr17:73,263,788...73,288,346
Ensembl chr17:78,175,398...78,197,636
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM2 mRNA
CTD
PMID:26941288
NCBI chr 4:121,346,434...121,360,962
Ensembl chr 4:122,903,682...122,918,094
G
Mcm3
minichromosome maintenance complex component 3
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM3 mRNA
CTD
PMID:26941288
NCBI chr 9:23,219,169...23,237,314
Ensembl chr 9:30,715,602...30,733,746
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM4 mRNA
CTD
PMID:26941288
NCBI chr11:85,258,443...85,272,144
Ensembl chr11:98,762,634...98,776,536
G
Mcm5
minichromosome maintenance complex component 5
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM5 mRNA
CTD
PMID:26941288
NCBI chr19:13,483,030...13,504,389
Ensembl chr19:13,488,813...13,517,758
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM6 mRNA
CTD
PMID:26941288
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:42,379,162...42,465,467
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MCM7 mRNA
CTD
PMID:26941288
NCBI chr12:17,042,207...17,049,470
Ensembl chr12:22,155,921...22,163,771
G
Mpo
myeloperoxidase
multiple interactions
ISO
[Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in decreased expression of MPO mRNA
CTD
PMID:12130515
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
G
Mt1a
metallothionein 1A
multiple interactions
ISO
hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT1 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT1 mRNA]
CTD
PMID:12042074
NCBI chr19:10,831,959...10,832,975
Ensembl chr17:79,695,809...79,696,200 Ensembl chr X:79,695,809...79,696,200 Ensembl chr19:79,695,809...79,696,200
G
Mt2
metallothionein 2
multiple interactions
ISO
hexamethylene bisacetamide promotes the reaction [[cobaltiprotoporphyrin binds to HPX protein] which results in increased expression of MT2 mRNA]; hexamethylene bisacetamide promotes the reaction [[mesoporphyrin IX binds to HPX protein] which results in increased expression of MT2 mRNA]
CTD
PMID:12042074
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,837,927...10,838,709
G
Myb
MYB proto-oncogene, transcription factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MYB protein
CTD
PMID:10597302
NCBI chr 1:17,759,309...17,793,306
Ensembl chr 1:17,759,309...17,792,547
G
Myc
MYC proto-oncogene, bHLH transcription factor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of MYC protein
CTD
PMID:10597302
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:95,483,105...95,488,028
G
Npm1
nucleophosmin 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of NPM1 protein
CTD
PMID:17569113
NCBI chr10:18,245,739...18,255,913
Ensembl chr10:18,245,740...18,256,024 Ensembl chr X:18,245,740...18,256,024
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
multiple interactions
ISO
[Hemin co-treated with hexamethylene bisacetamide] inhibits the reaction [CHD4 protein binds to OGT protein]
CTD
PMID:27231347
NCBI chr X:70,811,317...70,856,123
Ensembl chr X:70,811,319...70,856,123
G
Pml
PML nuclear body scaffold
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of PML protein mutant form
CTD
PMID:12130515
NCBI chr 8:67,523,164...67,557,801
Ensembl chr 8:67,523,164...67,576,083
G
Pola2
DNA polymerase alpha 2, accessory subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of POLA2 mRNA
CTD
PMID:26941288
NCBI chr 1:203,227,183...203,251,350
Ensembl chr 1:212,656,501...212,680,542
G
Pole
DNA polymerase epsilon, catalytic subunit
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of POLE mRNA
CTD
PMID:26941288
NCBI chr12:46,345,420...46,393,984
Ensembl chr12:52,005,155...52,053,662
G
Prim1
DNA primase subunit 1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of PRIM1 mRNA
CTD
PMID:26941288
NCBI chr 7:446,342...462,526
G
Prim2
DNA primase subunit 2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of PRIM2 mRNA
CTD
PMID:26941288
NCBI chr 9:35,692,376...35,904,521
Ensembl chr 9:43,188,350...43,398,990
G
Rara
retinoic acid receptor, alpha
multiple interactions
ISO
[Tretinoin co-treated with hexamethylene bisacetamide] results in increased cleavage of RARA protein mutant form
CTD
PMID:12130515
NCBI chr10:84,379,780...84,424,371
Ensembl chr10:84,389,622...84,425,160
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
hexamethylene bisacetamide results in decreased phosphorylation of RB1 protein
CTD
PMID:10597302
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:54,780,858...54,911,857
G
Rpa1
replication protein A1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA1 mRNA
CTD
PMID:26941288
NCBI chr10:60,148,869...60,199,970
Ensembl chr10:60,647,185...60,698,279
G
Rpa2
replication protein A2
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA2 mRNA
CTD
PMID:26941288
NCBI chr 5:144,976,789...144,989,445
Ensembl chr 5:150,260,723...150,271,546
G
Rpa3
replication protein A3
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of RPA3 mRNA
CTD
PMID:26941288
NCBI chr 4:36,304,649...36,307,755
Ensembl chr 4:37,270,966...37,274,183
G
RT1-Ba
RT1 class II, locus Ba
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-AA mRNA
CTD
PMID:26941288
NCBI chr20:4,577,057...4,581,650
Ensembl chr20:4,576,843...4,581,653
G
RT1-Bb
RT1 class II, locus Bb
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-AB1 mRNA
CTD
PMID:26941288
NCBI chr20:4,598,475...4,604,118
Ensembl chr20:4,598,475...4,604,118
G
RT1-Db1
RT1 class II, locus Db1
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of H2-EB1 mRNA
CTD
PMID:26941288
NCBI chr20:4,550,594...4,560,182
Ensembl chr20:4,550,596...4,560,165
G
Sin3b
SIN3 transcription regulator family member B
increases expression
ISO
hexamethylene bisacetamide results in increased expression of SIN3B protein
CTD
PMID:17569113
NCBI chr16:17,123,277...17,159,978
Ensembl chr16:17,157,352...17,270,664
G
Sla
src-like adaptor
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of SLA mRNA
CTD
PMID:26941288
NCBI chr 7:100,423,467...100,473,840
Ensembl chr 7:100,424,169...100,473,684
G
Slamf9
SLAM family member 9
decreases expression
ISO
hexamethylene bisacetamide results in decreased expression of SLAMF9 mRNA
CTD
PMID:26941288
NCBI chr13:84,941,896...84,944,749
Ensembl chr13:87,474,290...87,477,107
G
Srm
spermidine synthase
multiple interactions decreases expression
ISO
hexamethylene bisacetamide inhibits the reaction [BRD2 protein binds to SRM promoter] hexamethylene bisacetamide results in decreased expression of SRM mRNA
CTD
PMID:26941288
NCBI chr 5:159,025,875...159,029,076
Ensembl chr 5:164,308,991...164,332,705
G
Srsf1
serine and arginine rich splicing factor 1
increases expression
ISO
hexamethylene bisacetamide results in increased expression of SRSF1 protein
CTD
PMID:17569113
NCBI chr10:72,838,926...72,859,066
Ensembl chr10:73,336,422...73,342,548
G
Tubb4b
tubulin, beta 4B class IVb
increases expression
ISO
hexamethylene bisacetamide results in increased expression of TUBB4B protein
CTD
PMID:17569113
NCBI chr 3:8,037,838...8,040,294
Ensembl chr 3:28,435,148...28,439,719
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all